ArticleIranian journal of basic medical sciences2026
Carvacrol attenuated acute renal injury induced by unilateral ureteral obstruction in male rats.
Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Three-day unilateral ureteral obstruction (UUO) leads to acute renal injury. Carvacrol regulates inflammatory factors and reduces oxidative stress and apoptosis. Therefore, we are assessing the renoprotective effect of carvacrol against 3-day UUO in rats. Materials and Methods: Thirty-six male rats were randomized into six groups (n=6): control, carvacrol (100 mg/kg, IP), UUO, and UUO+carvacrol (25, 50, or 100 mg/kg). UUO was induced by ligating the left ureter for 3 days. Carvacrol was administered intraperitoneally once daily for three consecutive days, starting one hour after UUO induction. After treatment, hemodynamic parameters including mean arterial pressure (MAP), renal perfusion pressure (RPP), renal blood flow (RBF), and renal vascular resistance (RVR) were measured. Kidney function markers such as blood urea nitrogen (BUN) and serum creatinine were assessed. Oxidative stress and anti-oxidant status were evaluated by measuring malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), and total anti-oxidant capacity (TAC) in kidney tissue. Western blot analysis determined expression levels of Bax, Bcl-2, cleaved caspase-3, tumor necrosis factor alpha (TNF-α), and nuclear transcription factor p65 (NF-κB p65). Renal damage score (RDS) was surveyed by the hematoxylin and eosin method. Results: UUO significantly raised RVR, RDS, and MDA, serum creatinine, cleaved caspase-3, BUN, NF-κB p65, Bax, TNF-α protein levels ( Conclusion: Our study revealed that carvacrol protects against UUO-induced renal injury through its potent anti-oxidant, anti-inflammatory, and anti-apoptotic properties.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.